Samuel Paul Costello (S P Costello, Samuel P Costello, Sam Costello)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Venues

Alimentary pharmacology & therapeutics

Internal medicine journal

Gut

Drug testing and analysis

Queen Elizabeth Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen Elizabeth Hospital Feb 1o 2013

Australia

Gastroenterologist :: Gastroenterology

Publications

Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca G Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut (2023)
Jonathon P Schubert, Paul Robert Ingram, Morgyn S Warner, Christopher K Rayner, Ian C Roberts-Thomson, Samuel Paul Costello, Robert V Bryant
Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance. Internal medicine journal (2023)
Jared W Castle, Danielle M Butzbach, G Stewart Walker, Claire E Lenehan, Frank Reith, Samuel Paul Costello, Kenneth Paul Kirkbride
Microbial degradation products of lurasidone and their significance in postmortem toxicology. Drug testing and analysis (2023)
Jared W Castle, Danielle M Butzbach, G Stewart Walker, Claire E Lenehan, Frank Reith, Samuel Paul Costello, Kenneth Paul Kirkbride
In vitro degradation of ziprasidone in human whole blood. Drug testing and analysis (2022)
Alice Sarah Day, Chu Kion Yao, Samuel Paul Costello, Andrew Ruszkiewicz, Jane M Andrews, Peter R Gibson, Robert V Bryant
Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. The Journal of nutrition 152 (7) (2022)
Damjana Bogatic, Robert V Bryant, Kate D Lynch, Samuel Paul Costello
Microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary pharmacology & therapeutics (2022)
Jonathon P Schubert, Morgyn S Warner, Christopher K Rayner, Ian C Roberts-Thomson, Arduino A Mangoni, Samuel Paul Costello, Robert V Bryant
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years. Internal medicine journal (2021)
Samuel Paul Costello, Robert V Bryant
Editorial: faecal microbiota transplantation-the silver bullet for severe and fulminant Clostridioides difficile infection? Alimentary pharmacology & therapeutics 51 (1) (2020)
Robert V Bryant, Samuel Paul Costello
Editorial: assessing histological disease activity in Crohn's disease-a call for standardisation of mucosal biopsy location. Alimentary pharmacology & therapeutics 50 (1) (2020)
Al-Ani Aysha, Clarissa Rentsch, Ralley Prentice, Doug Johnson, Robert V Bryant, Mark G Ward, Samuel Paul Costello, Peter Lewindon, Simon Ghaly, Susan J Connor, Jakob Begun, Britt Christensen
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Internal medicine journal 50 (7) (2020)
Samuel Paul Costello, Alice Day, Chu K Yao, Robert Venning Bryant
Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis. BMJ case reports 13 (8) (2020)
Madeleine Gill, Charlotte Blacketer, Franco Chitti, Karmen Telfer, Lito Papanicolas, Lisa M Dann, Emily C Tucker, Robert V Bryant, Samuel Paul Costello
Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH open : an open access journal of gastroenterology and hepatology 4 (5) (2020)
Craig Haifer, Colleen R Kelly, Sudarshan Paramsothy, David Andresen, Lito E Papanicolas, Genevieve L McKew, Thomas J Borody, Michael Kamm, Samuel Paul Costello, Jane M Andrews, Jacob Begun, Hiu Tat Chan, Susan J Connor, Simon Ghaly, Paul Dr Johnson, Daniel A Lemberg, Ramesh Paramsothy, Andrew Redmond, Harsha Sheorey, David van der Poorten, Rupert W L Leong
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 69 (5) (2020)
Samuel Paul Costello, Robert V Bryant
Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal medicine journal 49 (2) (2019)
Samuel Paul Costello, W Soo, R V Bryant, Vipul Jairath, A L Hart, J M Andrews
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary pharmacology & therapeutics 46 (3) (2017)
Samuel Paul Costello, W Soo, R V Bryant, Vipul Jairath, A L Hart, J M Andrews
Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply. Alimentary pharmacology & therapeutics 46 (6) (2017)

Samuel Paul Costello.css-eqlu8i{font-size:small;padding-left:4px;} (S P Costello, Samuel P Costello, Sam Costello)

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel Paul Costello (S P Costello, Samuel P Costello, Sam Costello)